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Summary: Alkaline phosphatase (EC 3.1.3.1) activity increases 5-15 fold in the livers of rats, following bile duct
ligation. The mechanism of this increase has been the subject of numerous investigations. In HeLa cells the synthesis
of a different phosphatase enzyme protein with higher catalytic activity has been postulated.
After preparing an antiserum against rat liver phosphatase, we compared the phosphatase protein concentration in
normal and cholestatic livers by immunochemical titration. Our results clearly indicate that the elevation of enzyme
activity is due to an increased accumulation of enzyme protein.
Der Mechanismus des Aktivitätsanstiegs der alkalischen Leber phosphatase bei experimenteller Cholestase: Messung
einer erhöhten Enzymkonzentration durch Immuntitration
Zusammenfassung: Die Aktivität der alkalischen Phosphatase (EC 3.1.3.1) in Rattenleber steigt nach Unterbindung
des Gallenganges auf das 5— ISfache an. Der Mechanismus des Aktivitätsanstiegs ist trotz zahlreicher Untersuchungen
bisher nicht geklärt. In Analogie zu Befunden an HeLa-Zellen wurde postuliert, daß unter der Cholestase ein anders-
artiges, aktiveres Enzymprotein gebildet wird.
Nach Gewinnung eines Antiserums gegen gereinigte Rattenleberphosphatase verglichen wir mit der Methode der
Immuntitration die Phosphatasekonzentration in Kontroll- und Cholestaseleber. Hierfür mußte eine Zweischritt-
Immuripräzipitationstechnik angewandt werden, da der Antikörper direkt weder präzipitierende noch neutralisierende
Wirkung hatte. Unsere Ergebnisse zeigen eindeutig, daß die Zunahme der Enzymaktivität allein auf einer Zunahme
der Konzentration des Enzymproteins beruht.
Introduction more active enzyme protein was founded by Griffin &
The determination of serum alkaline phosphatase has Cox (4) on the basis of their studies ™ the cortisol-
been used for 40 years as an aid in the diagnosis of induced increase of phosphatase activity in HeLa cells,
cholestatic liver diseases, but the mechanism of the Fewerda &Stepan (5) investigated the rate of incorpora-
activity increase has not hitherto been elucidated. Ex- tlon of labelled Precursors into partially purified liver
periments on animals have shown that within one phosphatase, and concluded that also in the cholestatic
day after ligature of the bile duct, the increase in the llver of the rat> a ^ ore active phosphatase protein is
serum is paralleled by a 10-fold increase in the specific formed, which is different from that normally present,
activity of the liver alkaline phosphatase. This increase
 Qn other hand Righetti & Kapian (6) have shown
can be completely suppressed by inhibitors of protein recently essentially identical properties of the phos-
or nucleic acid synthesis. The dependence of this phatase from control and cholestatic liver. Our own
increase on the integrity of protein synthesis .suggests
 studies have indicated> too, complete identity of the
that it is the result of an increased de novo synthesis of
 two phosphatases in respect of their physicochemical
enzyme protein. Inhibitor studies must, however, be
 md kinetic behaviour (7).
interpreted with caution. Thus the concept of an activity
increase due to the de novö synthesis of a catalytically It appeared that immunological methods would be
necessary to give a definitive answer to the question of
~~ , r ,. w .· ·* *· u «. f + u Ä whether more enzyme, or a different enzyme withl) The results represent part of the Habilitationsschrift of the ' · . JJ J
author. greater catalytic activity is produced m cholestasis.
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Having obtained a suitable antiserum against rat
liver phosphatase, it was then possible to determine
the concentration of the specifically precipitated phos-
phatase protein in normal and cholestatic liver by
immunochemical titration.
Materials and Methods
Male Wistar-AF rats (Zentralinstitut f r Versuchstierzucht,
Hannover-Linden) weighing 200-220 g were used.
The animals were kept in a light controlled and air condi-
tioned room. They received the standard animal food Altromin
(Altrogge, Lage/Lippe) and water ad libitum.
The antiserum was produced in albino rabbits (New Zealand)
weighing 3—4 kg.
All reagents were reagent grade from E. Merck, Darmstadt, with
the following exceptions: Acrylamide and N'N-methylene-
bisacrylamide (Cyanogum 41), and dime thy laminopropionitrile
(Cyanogum 41 catalyst) were from Serva, Heidelberg. Complete
Freund's adjuvant was from Difco, Detroit, U.S.A. Antirabbit
-y-globulin serum from goat was from Behringwerke, Marburg.
Phosphatase activity was measured kinetically at 25°C with
continuous tracing of the change in absorbance in a photo-
meter Eppendorf with an automatic cuvette positioner and
recorder (Netheler und Hinz, Hamburg).
Polyacrylamide gel electrophoresis was performed in tubes
measuring 5 X 100 mm, with the aid of the apparatus supplied
by the firm of Boskamp, Hersel.
Bile duct ligation
The bile duct was iigated under ether anaesthesia by the
standard procedure.
After 24 hours the rats were bled by heart puncture and the
livers removed. Untreated animals served as control. For all
experiments the rats were fasted 16 hours prior to the
operation and until sacrificed.
Purification of liver alkaline phosphatase
The partial purification of the alkaline phosphatase was based
on the procedure reported by Morton (9) for bovine liver, and
modified by Engstr m (8). Details and results of the procedure
are to be found in I.e. (7). 25 choiestatic and 25 control livers
were subjected to «-butanol, acetone and ethanol fractionation
resulting in a 110 fold purification for both experimental
groups. All immunoprecipitation experiments were performed
with these two phosphatase preparations with specific activities
of 780 U/g protein and 9800 U/g respectively.
For immunization of the rabbits, the phosphatase from chole-
static liver was further purified by analytical polyacrylamide
gel electrophoresis (7) (7.5 % separation gel (Cyanogum), tris-
borate buffer 40 mmol/1, pH 8.8; 150 min, 2 mA/tube; quantity
applied: 75 /zg protein). This resulted in a further 6-10 fold
purification as estimated from parallel protein (Coomassie
blue) and phosphatase staining (glycine buffer pH 10, omaph-
thyl phosphate, Variamine blue salt B). Following Lc. (10),
the phosphatase-positive disc gel section was used as the antigen:
After electrophoresis, the phosphatase band was localized by
brief incubation in dilute p-nitrophenyl phosphate-buffer mix-
ture, then cut out. The sections of approximately 3 mm were
stored at - 20°.
Preparation of antiphosphatase serum
' 4 gel sections (= 2,5 U phosphatase) were suspended in 0.5 ml
physiological NaCi solution by repeated ejection through a
fine cannula. This suspension was mixed with complete Freundes
adjuvant and injected one rabbit at 6 different sites, right and
left of the vertebral column in the dorsal skin. This was
repeated after 2 and 4 weeks. 8 days after the last injection
blood was taken from the ear vein.
All the preparations of rabbit sera produced a precipitate after
2 days incubation (1 hour at 37°C, then 48 hours at 4°C) with
the phosphatase preparation from both the colestatic liver
and the control liver, but the alkaline phosphatase activity
remained unaltered in the 12 000 £ supernatant. A second incu-
bation of the supernatant with antirabbit-7-globulin serum
according to the method of Sussman (10) neither precipitated
nor neutralized the phosphatase.
One of the rabbits, treated as described above, was given a
booster injection after 6 months. This consisted of 0.4 mg of
a phosphatase preparation from cholestatic liver (specific
activity 20 000 U/g protein) which had been purified on
Sephadex G 200 (column 3 X 100 cm; elution buffer Tris/HCl,
pH 8, 0.1 mol/1, NaCl lmol/1). Serum taken 8 days later con-
tained antibodies against liver phosphatase, as shown by the "
double precipitation method.
Analytical Methods
Alkaline phosphatase (EC 3.1.3.1) was measured by the opti-
mized standard test (11), final concentrations: diethanolamine
buffer pH 9.8, 1 mol/1, MgCl2 0.5 mmol/1, p-nitrophenylphos-
phate 10 mmol/1. This method, as optimized for human serum,
was also found to be optimal for rat serum.
Protein was measured by the biuret method, low concentrations
were measured by the method of Lowry (12). Bovine albumin
(Behring Werke) was used as standard.
For details of the double precipation technique and the
immunochemical titration see Results and legends to the
figures.
Results
A marked precipitate was produced when phosphatase
preparations were incubated with antiserum for 1 hour
Ο .10 20 30 40
Aniirabbit serum [μΐ]
Fig. 1. Determination of the optimal quantity of antirabbit 7-
globulin serum from the goat required for the precipi-
tation of the phosphatase-antibody complex.
1st Step: incubation of 290 mil phosphatase with 20 /4
rabbit serum in a total volume of 1 ml NaCl; l h at 37°C,
then 48 h at 4°C, then centrifugation for 5 min at
12000g.
2nd Step: 20 μΐ supernatant + goat serum, total volume
70 μΐ; incubation l h at 37°C, then 24 h at 4°C. Residual
activity measured in the 12 000 g supernatant Results
presented after subtraction of the phosphatase activity
of the goat serum. Protein concentration in the precipi-
tate measured after washing with NaCl
• · rjhosphatase activity in the supernatant after sub-
traction of the goat serum phosphatase
ο ο phosphatase activity in the goat serum
A A
 protein in the irhmunpprecipitate
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at 37° C and finally 48 hours at 4°C. After centrifugation
for 5 minutes at 12 000 £, the phosphatase activity in
the supernatant was, however, the same as that in
parallel controls performed with serum from a non-
immunized rabbit or with NaCl. The soluble phosphatase-
antibody complex was then precipitated by the addition
of an antirabbit γ-globulin serum from goat. The
ratio of rabbit serum to goat serum is critical, and this
was strictly standardized in preliminary experiments.
Figure 1 shows the immunotitration curve for the deter-
mination of the optimal concentration of goat serum.
In the first step liver phosphatase was incubated with
*20 μ\ rabbit serum in 0.9 % NaCl in a total volume of
1 ml (see legend to Fig. 1). 20 μΐ aliquots of the super-
natant (concentration of rabbit serum 2 %) were incu-
bated with increasing volumes of goat serum. After cen-
trifugation, the remaining phosphatase activity in the
supernatant and the protein concentration in the preci-
pitate were measured. Since the goat serum also con-
tained a phosphatase activity of 68 U/l, the goat phos-
phatase activity added to each incubation mixture
(dotted line) was subtracted for the determination of
the rat liver phosphatase. As shown in the figure, the
equivalence point is at 40 μΐ goat serum. On the basis
of this determination, the following constant ratio was
chosen for the second step: 20 μ\ rabbit serum diluted
1:50 with physiological NaCl solution + 50 μΐ undiluted
goat serum.
The decisive question was whether a given quantity of
antiserum will precipitate all the phosphatase activity
from equal volumes of control and cholestatic phos-
phatase, in spite of the 12.5 fold higher specific activity
of the cholestatic preparation. This would be the case
if there is an unchanged quantity of enzyme, which
has been activated 12.5 fold. Figure 2 shows, however,
that a much greater quantity of antiserum is required
for the immunoprecipitation of 100 μΐ partially purified
phosphatase from cholestatic liver (for details see
legend) than for the precipitation of 100 μ\ of the con-
trol preparation.
The figure also shows the specificity of the reaction:
identical incubations with the serum of a non-immuni-
zed rabbit gave no precipitation, thereby excluding the
possibility of unspecific coprecipitation during the se-
cond precipitation step.
For a more exact determination of the quantitative
relationship, increasing volumes of phosphatase pre-
1000
Antiphosphatase serum [jut]
Fig. 2. Immune precipitation of partially purified alkaline phos-
phatase from control (o ο, Δ Δ) and cholestatic
liver (· ·, *—^A) with increasing quantities of anti-
serum.
100 μΐ phosphatase preparation (control 810 U/l, specific
activity 780 U/g protein, cholestatic liver 14 500 U/l,
specific activity 9800 U/g protein) were incubated with
rabbit serum in a total volume of 0.2 ml. After l h at
37°C and 48 h at 4°C, the 12 000 g supernatants were
adjusted to a final concentration of 2 % rabbit serum.
In the second step, 20 μΐ of this solution were incubated
with 50 μΐ goat serum. After centrifugation at 12 000 g,
the % phosphatase activity in the supernatant was correc-
ted for dilution and by subtracting the activity added
with the goat serum. The upper curves (Δ and *) show
the activities"in the supernatants of control incubations
with serum from a non-immunized rabbit.
10 20 40 100 200
Enzyme preparation [μΐ ] 500
1000
Fig. 3. Immunotitration of partially purified liver phosphatase
against a constant quantity of antiserum.
Incubation mixture: 20 μΐ antiserum + phosphatase pre-
paration (control 810 U/l, cholestatic 14500 U/l) + NaCl
to 1 ml total volume. Incubation for l h at 37°C and 48 h
at 4°C. For the 2nd step see legend to Fig. 1. Results
are presented on a double logarithmic scale.
Abscissa: μΐ phosphatase preparation in incubation mix-
ture.
Ordinate: U/l phosphatase activity in the supernatant
(including that of the goat serum phosphatase
of 45 U/l).
ο ο phosphatase from control liver
• · phosphatase from cholestatic liver
ο ο and · · enzyme activities in control incu-
bations with NaCl in place of goat scrum.
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paration were added to standard quantities of rabbit
serum (see Fig. 3). 20 μΐ antiserum precipitated the
phosphatase from more than 200 μΐ of the control
preparation, but it was only just sufficient for the
complete neutralization of 20 μΐ of the cholestatic pre-
paration. The equivalence points were estimated by
extrapolation: 270 μΐ control preparation containing
220 mU phosphatase activity are approximately equi-
valent to 18 μΐ cholestatic preparation containing 260
mU activity. Thus, any given quantity of antiserum
precipitates the same amount of phosphatase activity,
irrespective of whether the phosphatase is derived from
control or cholestatic liver.
This finding is confirmed by a different experiment
(Fig. 4), in which identical enzyme activities from
control and cholestatic liver were titrated against a
constant volume of antiserum. In accordance with the
higher specific phosphatase activity in the cholestatic
liver preparation (9800 U/g protein compared with
780 U/g), the latter was required in a smaller quantity.
In the incubation with the cholestatic preparation, the
liver protein concentration was consequently only 8%
of that in the control incubation. Nevertheless, the
equivalence points are in very good agreement at
260-270 mU phosphatase per 20 μΐ antiserum.
200
.£=100
1
S3
* 50
I
0.1 0.2 0.3
Phosphatase [U]
0,4 0.5
Fig. 4. Immunochemical titration of purified liver phosphatase
against constant quantities of antiserum.
For the titration, the same enzyme activities of control
and cholestatic liver enzyme preparations were used.
The incubation with cholestatic liver phosphatase thus
contained a 12.6 fold higher specific activity and only
8 % of the concentration of liver protein present in the
control incubation.
Incubations were performed as described in legend to
Fig. 3.
0
 ° control liver phosphatase · · cholestatic liver
phosphatase
Δ Δ and A A identical incubations with serum from
a nonimmunized rabbit. The horizontal dotted
line represents the phosphatase activity of the
goat serum.
Discussion
Unequivocal proof that de novo synthesis is responsible
for the increase in activity of alkaline phosphatase in
liver was hitherto lacking. By analogy with the findings
of Cox and his group (4, 13), it has always been consl··
dered possible that a different catalytically more active
phosphatase protein is formed in the liver. In HeLa cell
cultures, 1—4 days after the addition olcortisol, these
authors showed a 5—20 fold increase in the specific
activity, which could be inhibited by puromycin. Using
an antiserum against HeLa cell phosphatase, they showed
that the antibody concentration required for the
precipitation of a certain base level activity would also
precipitate the 5 fold activity of cortisol-ind ced phos-
phat se, yet the protein content of the two precipitates
was the same. The hormone-induced enzyme differed
from the basal enzyme in many physicochemieal.pro-
perties, such as temperature stability and behaviour on
Seph dex G 200. In 1971, the authors confirmed their
findings and postulated the production of a modifier
molecule responsible for the higher specific activity
of the induced-p'hosphatase (13). It was suggested that
a change in the specific binding of zinc at the catalytic
centre of the phosphatase was responsible for the al-
teration in activity.
Comparable studies on liver phosphatase were hitherto
not possible owing to the lack of a suitable antiserum.
On the basis of studies on the incorporation of labelled
amino acids into purified phosphatase, Fewerda &
Stepan (5) supported the hypothesis of a catalytically
activated enzyme in cholestatic liver: After 1000 fold
purification, the specific 14C-activity was the same in
the alkaline phosphatase from control and cholestatic
liver. According to the authors, this shows that there
is no increased synthesis of enzyme protein. Against
this interpretation is the fact that even a thousand fold
purification is not sufficient to resolve this question.
Engstr m (8) reported a 40 000 fold purification from
bovine liver. According to this, if a similar specific *
activity is assumed for bovine and rat liver, then the
thousand fold purified rat liver phosphatase still contains
about 98 % foreign protein. In our opinion, a 3—10 fold
increase in the 14C-activity of the 2 % of phosphatase
protein would be undetectable against the background
of general protein labelling.
After initial difficulties, we finally succeeded in
producing in one rabbit, a suitable antibody against rat
liver phosphatase. However, it was not possible to per-
form a direct reaction between the antigen and antibody,
because the antiserum neither neutralized nor precipi-
tated the liver phosphatase.
Using the method described bySussman (10) for their
antibody against human liver phosphatase; a second
immune reaction with an antirabbit γ-globulin from
the goat was used to precipitate the soluble antigen-
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antibody complex. After the standardization of this
second step, it was possible to perform a reliable immuno-
chemical titration.
Our results show that the quantity of antiserum for
complete precipitation depends only on the phospha-
tase activity, irrespective of whether the alkaline phos-
phatase is from control or cholestatic liver. The titration
curves of increasing phosphatase activity against con-
stant quantities of antiserum give identical equivalence
points for purified phosphatase from control and chole-
static liver. This proves unequivocally that cholestatic
liver simply contains more of the alkaline phosphatase
enzyme protein.
The theory of a different catalytically more active
phosphatase protein after bile duct ligation must now be
rejected. The elevated phosphatase activity in chole-
static liver is due exclusively to an increased concen-
tration of the enzyme protein.
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